Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Koichiro Morimoto
Observed name:
K Morimoto
Institutions:
Tokyo Medical and Dental University,
Institute of Science Tokyo
Observed institutions:
Tokyo Medical and Dental University,
Institute of Science Tokyo,
Shuuwa General Hospital
ORCID:
0009-0009-6885-4903
Observed ORCID:
0009-0009-6885-4903
OpenAlex ID:
A5016751666
PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
·
Molecular Cancer Research
·
7
Middle segment preserving pancreatectomy versus total pancreatectomy: a comparative analysis of short- and long-term outcomes
2024
·
Masahiro Yamane
, Yoshiya Ishikawa
, et al.
·
Surgery Today
·
2
[A Case of BRAF-Mutated Obstructive Colon Cancer with Liver Metastases Treated with Multidisciplinary Therapy].
2020
·
Kyoko Ryu
, Hiroshi Kuwabara
, et al.
·
PubMed
·
2
Supplementary Table S5 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Table S7 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Table S4 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S2 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Figure S9 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Table S8 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Table S2 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S11 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Data from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S6 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Table S6 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Table S1 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Table S3 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S10 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Figure S5 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Table S9 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S3 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Figure S4 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Methods from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S7 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Supplementary Figure S1 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
PDF
Supplementary Figure S8 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer
2025
·
Kentaro Umemura
, Yoshimitsu Akiyama
, et al.
Show more works
View as search
Works count:
28
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type